Donate COVID-19 Plasma
If you have fully recovered from COVID-19, you may be able to help patients currently fighting the infection by donating your plasma.
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Jul 22
Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine
Drugs
Jul 20
Hostess Brands, LLC Issues Voluntary Recall of Certain Hostess® Raspberry Zingers® Due to the Potential for Mold
Food & Beverages
Jul 20
LIQ-E S.A. de C.V. Issues Voluntary Recall of the Optimus Instant Hand Sanitizer Due to the Potential Presence of Undeclared Methanol
Drugs
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Potential Risks of Treatment with Unapproved Regenerative Medicine Products
FDA is providing resources to help consumers understand the risks associated with unapproved stem cell, exosome, and products marketed as regenerative medicine.
FDA’s Ongoing Work to Support and Advance COVID-19 Diagnostic Test Accuracy and Availability
FDA's actions are providing stakeholders with more accurate information about diagnostic test performance and allowing for the rapid availability of new tests.
FDA’s Continued Commitment to the Safety and Security of Our Laboratories
A cornerstone of the FDA’s scientific work is to ensure that we operate our laboratories and workplaces in a safe and secure manner.
Recently Published Guidances
Jul 21
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry
Drugs
Jul 21
Appeal Options Available to Mammography Facilities Concerning Adverse Accreditation Decisions, Suspension/Revocation of Certificates, or Patient and Physician Notification Orders
Medical Devices, Radiation-Emitting Products
Jul 20
Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use
Biologics